Difference between revisions of "Team:Fujian United"

Line 119: Line 119:
 
         </ul>
 
         </ul>
 
     </div>
 
     </div>
 
+
   
 
+
     <div class="content-outer">
     <!--动图-->
+
        <!--动图-->
    <div class="gif-logo">
+
        <div class="gif-logo">
        <img src="https://static.igem.org/mediawiki/2021/1/1e/T--Fujian_United--logo.gif" alt="">
+
            <img src="https://static.igem.org/mediawiki/2021/1/1e/T--Fujian_United--logo.gif" alt="">
    </div>
+
        </div>
 
+
      
     <!--banner-->
+
        <!--banner-->
    <div class="swiper-container">
+
        <div class="swiper-container">
        <div class="swiper-wrapper">
+
            <div class="swiper-wrapper">
            <div class="swiper-slide" style="background-image:url(https://static.igem.org/mediawiki/2021/1/16/T--Fujian_United--banner_1.jpg)"></div>
+
                <div class="swiper-slide" style="background-image:url(https://static.igem.org/mediawiki/2021/1/16/T--Fujian_United--banner_1.jpg)"></div>
            <div class="swiper-slide" style="background-image:url(https://static.igem.org/mediawiki/2021/2/25/T--Fujian_United--banner_2.jpg)"></div>
+
                <div class="swiper-slide" style="background-image:url(https://static.igem.org/mediawiki/2021/2/25/T--Fujian_United--banner_2.jpg)"></div>
            <div class="swiper-slide" style="background-image:url(https://static.igem.org/mediawiki/2021/7/7f/T--Fujian_United--banner_3.jpg)"></div>
+
                <div class="swiper-slide" style="background-image:url(https://static.igem.org/mediawiki/2021/7/7f/T--Fujian_United--banner_3.jpg)"></div>
 +
            </div>
 +
            <div class="swiper-pagination swiper-pagination-white"></div>
 +
        </div>
 +
   
 +
        <!--内容-->
 +
        <div class="content">
 +
            <!--ABSTRACT-->
 +
            <section class="article p-t-96 p-b-30">
 +
                <h1 class="title" style="margin: 0 0 64px !important;">ABSTRACT</h1>
 +
                <p style="font-size: 20px !important;">A new oral vaccine against rotavirus can help children get antibodies
 +
                    against rotavirus in a needle-free way. It can enter the child's body in the form of oral liquid, capsule,
 +
                    drink, etc. The oral form can facilitate rotavirus patients' treatment and prevent children from developing
 +
                    resistance. In this project, the construction and characterization of the plasmids for oral rotavirus
 +
                    vaccine production were completed in order to prepare the target vaccine. Genes for the β subunit of the
 +
                    heat-labile enterotoxin (LTB) from E. coli and the immunodominant outer core protein VP7 were cloned and
 +
                    expressed as a fusion protein. After being introduced into Bacillus subtilis, the plasmid could recognize
 +
                    rotavirus and express antigens LTB-VP7 successfully. This work here set the stage for the future development
 +
                    of the oral rotavirus vaccine.</p>
 +
            </section>
 +
   
 +
            <!--PROMOTIONAL VIDEO-->
 +
            <section class="promotional article p-b-54 p-t-96">
 +
                <h1 class="title">PROMOTIONAL VIDEO</h1>
 +
                <video src="https://static.igem.org/mediawiki/2021/d/d3/T--Fujian_United--video_index_1.mp4"
 +
                      controls preload="metadata"
 +
                      class="m-t-24"
 +
                      style="width: 100%; height: 100%">
 +
                </video>
 +
            </section>
 
         </div>
 
         </div>
        <div class="swiper-pagination swiper-pagination-white"></div>
 
    </div>
 
 
    <!--内容-->
 
    <div class="content">
 
        <!--ABSTRACT-->
 
        <section class="article p-t-96 p-b-30">
 
            <h1 class="title" style="margin: 0 0 64px !important;">ABSTRACT</h1>
 
            <p style="font-size: 20px !important;">A new oral vaccine against rotavirus can help children get antibodies
 
                against rotavirus in a needle-free way. It can enter the child's body in the form of oral liquid, capsule,
 
                drink, etc. The oral form can facilitate rotavirus patients' treatment and prevent children from developing
 
                resistance. In this project, the construction and characterization of the plasmids for oral rotavirus
 
                vaccine production were completed in order to prepare the target vaccine. Genes for the β subunit of the
 
                heat-labile enterotoxin (LTB) from E. coli and the immunodominant outer core protein VP7 were cloned and
 
                expressed as a fusion protein. After being introduced into Bacillus subtilis, the plasmid could recognize
 
                rotavirus and express antigens LTB-VP7 successfully. This work here set the stage for the future development
 
                of the oral rotavirus vaccine.</p>
 
        </section>
 
 
        <!--PROMOTIONAL VIDEO-->
 
        <section class="promotional article p-b-54 p-t-96">
 
            <h1 class="title">PROMOTIONAL VIDEO</h1>
 
            <video src="https://static.igem.org/mediawiki/2021/d/d3/T--Fujian_United--video_index_1.mp4"
 
                  controls preload="metadata"
 
                  class="m-t-24"
 
                  style="width: 100%; height: 100%">
 
            </video>
 
        </section>
 
 
     </div>
 
     </div>
  

Revision as of 15:23, 24 September 2021

ABSTRACT

A new oral vaccine against rotavirus can help children get antibodies against rotavirus in a needle-free way. It can enter the child's body in the form of oral liquid, capsule, drink, etc. The oral form can facilitate rotavirus patients' treatment and prevent children from developing resistance. In this project, the construction and characterization of the plasmids for oral rotavirus vaccine production were completed in order to prepare the target vaccine. Genes for the β subunit of the heat-labile enterotoxin (LTB) from E. coli and the immunodominant outer core protein VP7 were cloned and expressed as a fusion protein. After being introduced into Bacillus subtilis, the plasmid could recognize rotavirus and express antigens LTB-VP7 successfully. This work here set the stage for the future development of the oral rotavirus vaccine.

PROMOTIONAL VIDEO